Drug recall · January 6, 2021
NDC 64380-721-06 TACROLIMUS CAPSULES recall
Why: Failed Moisture Limits
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816
- Lots / codes
Lot 7242728A; June 2023
- Quantity
- 960 bottles
- Company
- Strides Pharma Inc., East Brunswick, NJ
- Distribution
- PA
- Initiated
- December 22, 2020 · Voluntary: Firm initiated
- Classified
- December 30, 2020
- Reported
- January 6, 2021
- Ended
- January 26, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tacrolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.